GEN News Highlights: Dec 12, 2006

Coriell Awarded $3.1M For Next Phase of the HapMap Project

(Page 1 of 1)

    The Coriell Institute for Medical Research was awarded a $3.1 million contract from the NHGRI to establish a sample repository for human genetic research.

    The new repository will house samples for genetic research, including the samples collected for the International HapMap Project. The International HapMap Project produced a resource with 3.9 million SNPs typed in each of the samples. The next effort is to expand the repository to include samples from seven additional populations.

    The NHGRI initially worked with the Human Genetic Cell Repository at Coriell to establish, store, and distribute the cell lines and DNA studied to develop the HapMap.

    Coriell will help communicate with the various donor communities directly as well as in collaboration with NHGRI. Each of the communities where samples were collected for the HapMap has a community advisory group, through which the Repository can communicate to the community the importance and results of research using the HapMap.

     


Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll